Research Article

Related GMR Articles

09/28/2015
Diagnosis; Enzyme-linked immunospot; Meta-analysis; Tuberculous pleurisy

Current methods for diagnosing tuberculous pleurisy are poor. Some studies have explored the diagnostic value of a pleural effusion enzyme-linked immunospot (ELISPOT) assay, but its accuracy remains controversial. Therefore, we performed a meta-analysis of the existing evidence on the ability of the ELISPOT assay to diagnose tuberculous pleurisy. We systematically searched PubMed, Google ... more

Z.Z. Li; W.Z. Qin; L. Li; Q. Wu; Y.J. Wang
09/28/2015
Biomarker; Diagnosis; HCC; miR-21; Prognosis

The diagnostic and prognostic value of miR-21 has been examined for hepatocellular carcinoma (HCC), with inconsistent results. Present meta-analysis summarized the diagnostic accuracy and the predictive role for survival of miR-21 in patients with HCC. All eligible studies were searched using PubMed, EMBASE, and Chinese National Knowledge Infrastructure (CNKI) databases up to October 2014 ... more

S.R. Yan; Z.J. Liu; S. Yu; Y.X. Bao
07/03/2015
Diagnosis; Meta-analysis; MicroRNAs; Thyroid cancer

The aim of this meta-analysis was to systematically evaluate the diagnostic accuracy of microRNAs (miRNAs) in distinguishing malignant thyroid lesions from benign ones and to determine the potential of miRNAs as diagnostic biomarkers for thyroid cancer. The random-effect model was used to summarize the pooled estimates of diagnostic accuracy, including sensitivity, specificity, positive ... more

G.J. Zhou; M. Xiao; L.N. Zhao; J.G. Tang; L. Zhang
12/29/2015
Biomarker; Diagnosis; Ewing's sarcoma; miR-125; Serum

Previous studies indicated that microRNA-125b (miR-125b) has an important role in the progression of Ewing’s sarcoma (ES). The purpose of the current study was to examine expression changes of miR-125b in the serum of ES patients and evaluate if the expression level of miR-125b could serve as a new biomarker for ES. This study was performed on patients who underwent surgical resection at ... more

C.L. Nie; W.H. Ren; Y. Ma; J.S. Xi; B. Han
01/29/2016
Brain natriuretic peptide; Cardiovascular disease; Diagnosis; Functional association analysis; Gene expression profile

Previous studies have used microarray technology to explore gene expression differences between the atrium and the ventricle. However, selection criteria for the differentially expressed genes (DEGs) based only on either the fold change or the P value in these studies. Here, we aim to further identify the DEGs by setting a P value threshold of <0.05 and a fold change of >2, which ... more

Y. Zhi; Z. Cao; Q.H. Li; X.L. Li; Y. Sun; T. Zhang; Q. Zhang; Y. Zhi; Z. Cao; Q.H. Li; X.L. Li; Y. Sun; T. Zhang; Q. Zhang; Y. Zhi; Z. Cao; Q.H. Li; X.L. Li; Y. Sun; T. Zhang; Q. Zhang
11/03/2016
Diagnosis; Lung cancer; Lung cancer screen; Serum tumor markers

Early detection and treatment is critically important for lung cancer patients. Inflammatory mediators such as IL-6, IL-10, and MCP-1 participate in lung cancer regulation. CEA, CA125, and ProGRP are commonly used serum tumor markers for lung cancer. In this study, we assessed the sensitivity and specificity of CEA, CA125, and ProGRP when used in combination with ... more

Y.W. Pan; Z.G. Zhou; M. Wang; J.Q. Dong; K.P. Du; S. Li; Y.L. Liu; P.J. Lv; J.B. Gao; Y.W. Pan; Z.G. Zhou; M. Wang; J.Q. Dong; K.P. Du; S. Li; Y.L. Liu; P.J. Lv; J.B. Gao